Ethanol-resistant ethylcellulose/guar gum coatings--importance of formulation parameters. 2013

Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
Univ. Lille Nord de France, College of Pharmacy, Lille, France; INSERM U 1008, Controlled Drug Delivery Systems and Biomaterials, Lille, France.

Recently, ethylcellulose/guar gum blends have been reported to provide ethanol-resistant drug release kinetics from coated dosage forms. This is because the ethanol insoluble guar gum effectively avoids undesired ethylcellulose dissolution in ethanol-rich bulk fluids. However, so far the importance of crucial formulation parameters, including the minimum amount of guar gum to be incorporated and the minimum required guar gum viscosity, remains unclear. The aim of this study was to identify the most important film coating properties, determining whether or not the resulting drug release kinetics is ethanol-resistant. Theophylline matrix cores were coated in a fluid bed with blends of the aqueous ethylcellulose dispersion "Aquacoat®ECD30" and guar gum. The polymer blend ratio, guar gum viscosity, and degree of dilution of the final coating dispersion were varied. Importantly, it was found that more than 5% guar gum (referred to the total polymer content) must be incorporated in the film coating and that the apparent viscosity of a 1% aqueous guar gum solution must be greater than 150 cP to provide ethanol-resistance. In contrast, the investigated degree of coating dispersion dilution was not found to be decisive for the ethanol sensitivity. Furthermore, all investigated formulations were long term stable, even upon open storage under stress conditions for 6 months.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008351 Mannans Polysaccharides consisting of mannose units. Mannan
D008855 Microscopy, Electron, Scanning Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY. Scanning Electron Microscopy,Electron Scanning Microscopy,Electron Microscopies, Scanning,Electron Microscopy, Scanning,Electron Scanning Microscopies,Microscopies, Electron Scanning,Microscopies, Scanning Electron,Microscopy, Electron Scanning,Microscopy, Scanning Electron,Scanning Electron Microscopies,Scanning Microscopies, Electron,Scanning Microscopy, Electron
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D005685 Galactans Polysaccharides composed of repeating galactose units. They can consist of branched or unbranched chains in any linkages. Galactan,Polygalactose,Polygalactoses

Related Publications

Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
June 2007, Yao xue xue bao = Acta pharmaceutica Sinica,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
October 1990, Ancient science of life,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
April 1983, Gastroenterologie clinique et biologique,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
July 2010, Research in pharmaceutical sciences,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
January 1990, Duodecim; laaketieteellinen aikakauskirja,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
May 2011, Bioresource technology,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
October 1982, Atherosclerosis,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
August 2013, Journal of veterinary pharmacology and therapeutics,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
January 2013, BioMed research international,
Y Rosiaux, and C Velghe, and S Muschert, and R Chokshi, and B Leclercq, and F Siepmann, and J Siepmann
May 1990, DICP : the annals of pharmacotherapy,
Copied contents to your clipboard!